Larimar Therapeutics, Inc. (LRMR) News Headlines

▮ More

Date

Headline

6/9/2020 11:28:42 AM Dwindling Prader-Willi Syndrome Drug Development Landscape And Hopeful Therapies

12/18/2019 6:04:21 AM Zafgen And Chondrial Therapeutics Enter Definitive Merger Agreement

9/5/2019 7:36:07 AM Zafgen To Explore Strategic Options After FDA Hold On ZGN-1061 - Quick Facts

9/5/2019 7:12:19 AM Zafgen Plans To Explore Strategic Options

5/30/2019 7:04:55 AM Zafgen Reports Receipt Of Minutes From Type A Meeting With FDA

3/13/2019 12:34:24 AM 5 Top Losers In Healthcare Sector (ZFGN, TNXP, ENZ...)

3/12/2019 2:12:15 AM Zafgen Scraps Another Prader-Willi Syndrome Drug Candidate

1/17/2019 11:15:09 PM FDA Turns Down IMMU's Breast Cancer Drug, ZYME/LLY Deal Progresses, ZFGN Abuzz

1/17/2019 7:03:54 AM Zafgen Announces Positive Data For Second Cohort Of Its Phase 2 Clinical Trial Of ZGN-1061

11/26/2018 10:49:44 PM ZFGN Hit By Clinical Hold, EQ For The Long Haul, MBOT On Watch

11/26/2018 7:03:42 AM Zafgen Provides Update On Investigational New Drug Application For ZGN-1061

8/2/2018 4:32:40 PM Navitor Pharmaceuticals Appoints Thomas Hughes As CEO

7/6/2018 5:06:09 AM In The Spotlight: Zafgen

6/28/2018 8:52:11 PM QURE Exudes Hope, ZFGN Catches Eyes, NDRA On Watch, XENE Hits New High

6/28/2018 8:05:03 AM Zafgen Announces Pricing Of Offering Of 8 Mln Shares At $7.50/Shr

6/27/2018 4:04:00 PM Zafgen Announces Proposed Offering Of Common Stock

6/25/2018 10:10:18 PM XBIO Explodes Over 100%, ZFGN Abuzz, NTRA Grabs Investors' Attention

6/24/2018 11:21:12 PM LLY Scores Win In Alimta Patent Suit, LXRX For The Long Haul, MNKD Breathes Easy

6/23/2018 10:34:36 AM Zafgen: Phase 2 Proof-of-Concept Trial Of ZGN-1061 Meets All Primary Objectives

6/16/2018 12:39:56 PM An Ear To The Pharma: 5 Stocks To Watch (OBSV, GERN, SRPT…)

Latest Headlines